Antidepressants may increase risk of death by 20 percent for those with progressive lung disease

June 26, 2018, St. Michael's Hospital
Study from St. Michael's Hospital finds antidepressants may increase risk of death by 20 percent for people with progressive lung disease. Credit: St. Michael's Hospital

Antidepressant use in people with chronic obstructive pulmonary disease (COPD) is associated with a 20 per cent increase in likelihood of death and a 15 per cent increase in likelihood of hospitalization due to related symptoms, finds a new study led by researchers at St. Michael's Hospital.

Published today in the European Respiratory Journal, the research suggests that amongst adults with COPD, new users of serotonergic antidepressants—a specific class of the —have higher rates of hospitalization, , and mortality related to respiratory conditions, as well as death overall versus non-users of the medications. While the study does not show cause and effect, it suggests strong association.

"We were not surprised by these findings, as there are biological reasons why antidepressants could lead to respiratory issues," said Dr. Nicholas Vozoris, a scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital and the lead author. "These drugs can cause sleepiness, vomiting and can negatively impact immune system cells. This increases the likelihood of infections, breathing issues, and other respiratory adverse events, especially in patients with COPD."

COPD is a progressive lung disease that causes increasing breathlessness. It affects more than 10 per cent of those aged 40 and older worldwide. Because of the nature of the disease, upwards of 70 per cent of those with COPD also struggle with symptoms of low mood and anxiety, said Dr. Vozoris, who is also an assistant professor in the Department of Medicine at the University of Toronto and a respirologist at St. Michael's.

Using health administrative databases from the Institute of Clinical Evaluative Sciences (ICES), Dr. Vozoris and his team studied 28,360 new users of serotonergic antidepressants with COPD aged 66 and older and matched them to an equivalent amount of non-users. The analysis revealed that among older adults with COPD, new users of this class of medication have modest, but significant, increases in rates of breathing-related death and all causes of death. The research showed a strong association, but not a definite cause and effect.

"The study results should not cause alarm among those who use these medications, but rather increase caution among patients and physicians," Dr. Vozoris said. "I hope our study encourages increased awareness when prescribing these medications and monitoring for adverse side effects. Also, because there is this association, we as physicians should give thought to psychotherapy and pulmonary rehabilitation as non-drug related treatment."

Dr. Vozoris plans to continue to study other classes of medications used for treatment of psychological issues in patients with COPD to build a more complete picture of medication risks.

Explore further: Study finds adverse respiratory outcomes for older people with COPD taking benzodiazepines

Related Stories

Study finds adverse respiratory outcomes for older people with COPD taking benzodiazepines

April 17, 2014
A group of drugs commonly prescribed for insomnia, anxiety and breathing issues "significantly increase the risk" that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency ...

New opioid use in older adults with COPD associated with increased risk of death

July 14, 2016
Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers ...

New opioid use in older adults with COPD associated with increased risk of cardiac death

June 29, 2017
Older adults with chronic obstructive pulmonary disorder who recently started using opioids have an increased risk of coronary artery disease-related death compared to non-opioid users, researchers at St. Michael's Hospital ...

Frequently prescribed drug used in concerning ways with harmful side effects

February 6, 2013
A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.

High opioid use in older people with COPD raises safety concerns

October 2, 2015
Researchers are raising safety concerns about high rates of new opioid use among older adults with chronic obstructive pulmonary disease, according to a new study published today in the British Journal of Clinical Pharmacology.

Risk of adverse medication reactions to people with COPD

January 15, 2018
Those with Chronic Obstructive Pulmonary Disease (COPD), together with other chronic illnesses, are at greater risk of adverse medication reactions, according to a new study‌.

Recommended for you

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Insulin shows great potential against chronic colitis

September 24, 2018
Diabetes is not the only disease on which insulin has an effect, it appears. In a new study using tests on mice, researchers from the University of Copenhagen, among others, have discovered a new method for treating chronic ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.